These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 39223811

  • 1. Study of Risk Factors Associated With Recurrent Primary Sclerosing Cholangitis After Liver Transplantation in Shiraz >From 2011 to 2021.
    Taghavi SA, Safarpour AR, Ghahramani S, Moghadam SM, Shahramian I, Sivandzadeh GR, Nikeghbalian S, Tahani M, Saeian S, Malek-Hosseini SA.
    Exp Clin Transplant; 2024 Jul; 22(7):531-539. PubMed ID: 39223811
    [Abstract] [Full Text] [Related]

  • 2. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients.
    Venkat VL, Ranganathan S, Mazariegos GV, Sun Q, Sindhi R.
    Liver Transpl; 2014 Jun; 20(6):679-86. PubMed ID: 24634351
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.
    Henson JB, Patel YA, Wilder JM, Zheng J, Chow SC, King LY, Muir AJ.
    Dig Dis Sci; 2017 Nov; 62(11):3200-3209. PubMed ID: 28391417
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.
    Kugelmas M, Spiegelman P, Osgood MJ, Young DA, Trotter JF, Steinberg T, Wachs ME, Bak T, Kam I, Everson GT.
    Liver Transpl; 2003 Jul; 9(7):727-32. PubMed ID: 12827560
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM.
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [Abstract] [Full Text] [Related]

  • 12. Frequent overlap of active hepatitis in recurrent primary sclerosing cholangitis after living-donor liver transplantation relates to its rapidly progressive course.
    Miyagawa-Hayashino A, Egawa H, Yoshizawa A, Ueda Y, Ichida T, Ueno Y, Uemoto S, Harada K, Nakanuma Y.
    Hum Pathol; 2011 Sep; 42(9):1329-36. PubMed ID: 21334714
    [Abstract] [Full Text] [Related]

  • 13. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis.
    Hildebrand T, Pannicke N, Dechene A, Gotthardt DN, Kirchner G, Reiter FP, Sterneck M, Herzer K, Lenzen H, Rupp C, Barg-Hock H, de Leuw P, Teufel A, Zimmer V, Lammert F, Sarrazin C, Spengler U, Rust C, Manns MP, Strassburg CP, Schramm C, Weismüller TJ, German PSC Study Group.
    Liver Transpl; 2016 Jan; 22(1):42-52. PubMed ID: 26438008
    [Abstract] [Full Text] [Related]

  • 14. Factors Associated With Recurrence of Underlying Diseases Among Liver Transplant Recipients: A Single-Center Study.
    Shamsaeefar A, Shojaei S, Nikoupour H, Mashhadiagha A, Moosavi SA, Sayadi M, Gholami S, Motazedian N, Geramizadeh B, Malekhosseini SA.
    Exp Clin Transplant; 2024 May; 22(5):366-372. PubMed ID: 38970279
    [Abstract] [Full Text] [Related]

  • 15. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
    Kirstein MM, Book T, Manns MP, von Hahn T, Voigtländer T.
    United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
    [Abstract] [Full Text] [Related]

  • 16. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India.
    Jadaun SS, Mehtani R, Hasnain A, Bhatia S, Moond V, Kumar M, Kuhad V, Singh S, Agarwal S, Gupta S, Saigal S.
    Hepatol Int; 2023 Apr; 17(2):499-506. PubMed ID: 36376772
    [Abstract] [Full Text] [Related]

  • 17. Clinical analysis of liver transplantation in autoimmune liver diseases.
    Zhong CP, Xi ZF, Xia Q.
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):27-31. PubMed ID: 29428100
    [Abstract] [Full Text] [Related]

  • 18. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.
    Alabraba E, Nightingale P, Gunson B, Hubscher S, Olliff S, Mirza D, Neuberger J.
    Liver Transpl; 2009 Mar; 15(3):330-40. PubMed ID: 19243003
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk factors for recurrent autoimmune liver diseases after liver transplantation: A meta-analysis.
    Chen C, Ke R, Yang F, Cai Q, Liu J, Huang X, Chen J, Xu F, Jiang Y.
    Medicine (Baltimore); 2020 May; 99(20):e20205. PubMed ID: 32443344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.